Skip to main content
MDxHealth SA logo

MDxHealth SA — Investor Relations & Filings

Ticker · MDXH ISIN · BE0974461940 LEI · 549300J3MG9F9B5FY646 BR Human health and social work activities
Open in API
Filings indexed 940 across all filing types
Latest filing 2023-06-06 AGM Information
Country BE Belgium
Listing BR MDXH

About MDxHealth SA

https://mdxhealth.com/

MDxHealth SA is a commercial-stage precision diagnostics company that provides actionable molecular information to personalize the diagnosis and treatment of urologic conditions. The company's portfolio of tests is designed to assist clinicians in making more informed decisions. For prostate cancer, its products include Select mdx, which assesses a patient's risk to help determine if a biopsy can be safely avoided; Confirm mdx, which addresses biopsy sampling errors; and the GPS (Genomic Prostate Score) test, a genomic assay that helps guide treatment decisions for men with localized disease. Additionally, the company offers Resolve mdx, a test that aids in selecting appropriate treatment for patients presenting with symptoms of urinary tract infections (UTIs).

Recent filings

Filing Released Lang Actions
PR 2023 06 05.pdf
AGM Information Classification · 98% confidence The document is explicitly titled "MDxHealth Announces its Extraordinary General Shareholders' Meeting" and details the date, time, and agenda for this meeting. The agenda items include the issuance of a new share option plan and renewal of authorization for share capital increase. This content directly relates to the formal proceedings and materials associated with a General Shareholders' Meeting. Therefore, the most appropriate classification is AGM Information (AGM-R). Although it is an announcement, the core subject matter is the meeting itself, which aligns better with AGM-R than a general Report Publication Announcement (RPA) or Regulatory Filing (RNS).
2023-06-06 English
PR 2023 06 05 FR.pdf
AGM Information Classification · 98% confidence The document is a press release dated June 5, 2023, titled "MDxHealth annonce son assemblée générale extraordinaire des actionnaires" (MDxHealth announces its extraordinary general meeting of shareholders). It explicitly invites shareholders to an Extraordinary General Meeting (EGM) scheduled for June 30, 2023. The agenda includes issuing a new share option plan and renewing authorization for capital increase. This content directly relates to shareholder meetings and the associated governance/voting materials. Since it is an announcement about an upcoming meeting, and the agenda involves capital structure changes (share options/capital increase), it strongly aligns with the purpose of an AGM/EGM announcement. The most specific code for meeting-related materials is AGM-R (AGM Information), as EGMs are functionally similar to AGMs in terms of shareholder interaction and voting.
2023-06-06 French
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, MDxHealth SA, pursuant to SEC rules. It provides information related to an Extraordinary General Shareholders' Meeting, including exhibits such as convening notice, attendance form, proxy form, voting forms, outstanding shares and voting rights, and a press release. The document does not contain financial statements or detailed financial analysis but rather materials related to a shareholders' meeting and voting procedures. The length is 3606 characters, which is relatively short and consistent with a regulatory filing or announcement rather than a full report. The content aligns with regulatory filings that provide updates or notices required by law but are not full annual or interim reports. Therefore, the best classification is Regulatory Filings (RNS).
2023-06-06 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It includes a press release attached as Exhibit 99.1 dated May 25, 2023. The document states that the information is being furnished and shall not be deemed "filed" for certain regulatory purposes, indicating it is an announcement rather than a full report. The document length is 3229 characters, which is relatively short and consistent with a regulatory filing or announcement rather than a full financial report. There is no substantive financial data or detailed report content present, only a reference to a press release. According to the rules, such documents are classified as Regulatory Filings (RNS) when they do not fit other categories and are primarily announcements or filings without full report content.
2023-05-26 English
PR 2023 05 25 EN.pdf
AGM Information Classification · 99% confidence The document explicitly announces the results of the company's 'Annual and Extraordinary General Shareholders' Meetings' (AGM and EGM). It details that resolutions were passed at the AGM and mentions the scheduling of a subsequent EGM. This content directly relates to the proceedings and outcomes of a general shareholders' meeting. Therefore, the appropriate classification is AGM Information (AGM-R). The document length (2259 chars) is substantial enough to be the primary announcement, not just a brief RPA.
2023-05-25 English
PR 2023 05 25 FR.pdf
AGM Information Classification · 98% confidence The document is titled "MDxHealth annonce les résultats de ses assemblées générales ordinaire et extraordinaire des actionnaires" (MDxHealth announces the results of its ordinary and extraordinary general meetings of shareholders). It explicitly discusses the holding of the Annual General Meeting (AGO) and an Extraordinary General Meeting (AGE), the resolutions voted upon, and the outcome (propositions duly adopted for the AGO, and the need for a second AGE). This content directly relates to the proceedings and results of shareholder meetings. The most fitting category is AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting (AGM). Although it announces results, the core subject matter is the meeting itself, making AGM-R more specific than DVA (Declaration of Voting Results) or RPA (Report Publication Announcement). Given the context of announcing the results of the AGM, AGM-R is the primary classification.
2023-05-25 French

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.